Insurers Caution Against HRAs for Short-Term Health Plans

Article

The health insurance industry cautioned the Trump administration against allowing health reimbursement accounts (HRAs) to be used to purchase short-term limited duration health plans, in comments submitted regarding a proposed rule change.

The health insurance industry cautioned the Trump administration against allowing health reimbursement accounts (HRAs) to be used to purchase short-term limited duration health plans (STLDHPs), in comments submitted regarding a proposed rule change.

Both America’s Health Insurance Plans (AHIP) and the Blue Cross Blue Shield Association (BSBCA) said that the change would allow unbalanced risk pools, as healthier employees might opt for a combination of an HRA integrated with a short-term plan. Such a change would cause negative effects through the insurance industry nationwide, they said.

Comments to the administration on the proposed rule, announced in October 2018, were due last Friday.

AHIP and BCBSA said that the administration should protect nondiscrimination “guardrails” by requiring individuals participating in an HRA to continue to be enrolled in comprehensive individual health insurance or through group coverage offered by an employer.

Continue reading on The American Journal of Managed Care.

Related Videos
pharmacy oncology, Image Credit: © Konstantin Yuganov - stock.adobe.com
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff - stock.adobe.com
Mayo Clinic oncology pharmacy
A panel of 3 experts on multiple myeloma
A panel of 3 experts on multiple myeloma
A panel of 3 experts on hepatic encephalopathy
A panel of 3 experts on hepatic encephalopathy
A panel of 5 experts on ASCVD
© 2024 MJH Life Sciences

All rights reserved.